MICROSATELLITE STABLE COLORECTAL CANCER
Clinical trials for MICROSATELLITE STABLE COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new MICROSATELLITE STABLE COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for MICROSATELLITE STABLE COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy shows promise for Hard-to-Treat cancers
Disease control CompletedThis study tested a combination of two drugs, NT-I7 and pembrolizumab, in 215 people with advanced solid tumors that had come back or stopped responding to treatment. The goal was to find a safe dose and see if the combo could shrink tumors. The study included people with several…
Matched conditions: MICROSATELLITE STABLE COLORECTAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: NeoImmuneTech • Aim: Disease control
Last updated May 26, 2026 03:05 UTC
-
New hope for advanced colon cancer: immunotherapy shrinks tumors in some patients
Disease control CompletedThis study tested a drug called nivolumab, alone or with other cancer drugs, in 385 people whose colon cancer had returned or spread. The goal was to see if the treatment could shrink tumors in patients whose cancers have a specific genetic feature (MSI-H). The approach uses the …
Matched conditions: MICROSATELLITE STABLE COLORECTAL CANCER
Phase: PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 22, 2026 14:04 UTC